手术仍然是 I 期非小细胞肺癌的最佳治疗方法吗？
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
机构信息
1 Hunter Holmes McGuire VA Medical Center, Virginia Commonwealth University, Richmond, VA 23224, USA ; 2 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
出版信息
Transl Lung Cancer Res. 2016 Apr;5(2):183-9. doi: 10.21037/tlcr.2016.04.05.
Abstract
There is debate about what is the optimal treatment for operable stage I non-small cell lung cancer (NSCLC). Although surgery has been the standard of care for centuries, recent retrospective and prospective randomized studies indicated that stereotactic ablative radiotherapy (SABR) could be an option for this group of patients with similar survival and less toxicities. However, to change the standard of care, more studies are needed and participating ongoing larger randomized studies is the best approach to resolve this controversy.
摘要
对于可手术的 I 期非小细胞肺癌（NSCLC），哪种治疗方法最佳存在争议。尽管手术已成为数百年的治疗标准，但最近的回顾性和前瞻性随机研究表明，立体定向消融放疗（SABR）可能是这组患者的一种选择，其生存情况相似，毒性更小。然而，要改变治疗标准，还需要更多的研究，参与正在进行的更大规模的随机研究是解决这一争议的最佳方法。
相似文献
1
Is surgery still the optimal treatment for stage I non-small cell lung cancer?手术仍然是 I 期非小细胞肺癌的最佳治疗方法吗？
Transl Lung Cancer Res. 2016 Apr;5(2):183-9. doi: 10.21037/tlcr.2016.04.05.
2
Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.关于 I 期非小细胞肺癌的进一步数据：手术与立体定向消融放疗的比较。
Ann Transl Med. 2015 Aug;3(13):172. doi: 10.3978/j.issn.2305-5839.2015.07.26.
3
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.立体定向体部放疗或立体定向消融放疗与手术治疗T1-3N0M0期非小细胞肺癌患者的疗效比较：一项系统评价和荟萃分析
Onco Targets Ther. 2017 Jun 7;10:2885-2892. doi: 10.2147/OTT.S138701. eCollection 2017.
4
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.立体定向消融放疗与肺叶切除术治疗可手术的Ⅰ期非小细胞肺癌：两项随机试验的汇总分析
Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13.
5
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?手术还是立体定向消融放疗：在未来，早期非小细胞肺癌的可手术患者将如何治疗？
Ann Transl Med. 2015 Feb;3(2):25. doi: 10.3978/j.issn.2305-5839.2015.01.06.
6
Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.立体定向消融放疗（SABR）较肺叶切除术治疗早期非小细胞肺癌（NSCLC）可提高生存率：解决突破性随机数据的影响。
Ann Transl Med. 2015 Jul;3(11):149. doi: 10.3978/j.issn.2305-5839.2015.06.15.
7
Survival Outcome after Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis.立体定向体部放射治疗联合手术治疗早期非小细胞肺癌的生存结局：一项荟萃分析。
J Invest Surg. 2017 Aug 22;31(5):440-447. doi: 10.1080/08941939.2017.1341573.
8
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.早期非小细胞肺癌的立体定向放射治疗：当前标准与正在进行的研究。
Transl Lung Cancer Res. 2021 Apr;10(4):1930-1949. doi: 10.21037/tlcr-20-860.
9
Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer - A Done Deal?立体定向消融放疗治疗早期肺癌——已成定局？
Clin Oncol (R Coll Radiol). 2022 Nov;34(11):733-740. doi: 10.1016/j.clon.2022.08.027. Epub 2022 Aug 30.
10
Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more.早期非小细胞肺癌的手术与立体定向消融放疗（SABR）：少并非多。
J Thorac Dis. 2016 Apr;8(Suppl 4):S399-405. doi: 10.21037/jtd.2016.04.40.
引用本文的文献
1
Racial disparities in staging, treatment, and mortality in non-small cell lung cancer.非小细胞肺癌在分期、治疗和死亡率方面的种族差异。
Transl Lung Cancer Res. 2024 Jan 31;13(1):76-94. doi: 10.21037/tlcr-23-407. Epub 2024 Jan 29.
2
A single institutional experience with central lung stereotactic body radiation therapy demonstrating encouraging results with increased inter-fraction time.一项关于中央肺部立体定向体部放射治疗的单机构经验显示，增加分次治疗间隔时间可取得令人鼓舞的结果。
J Thorac Dis. 2021 Feb;13(2):642-652. doi: 10.21037/jtd-20-2659.
3
Strategic Initiatives for Veterans with Lung Cancer.针对肺癌退伍军人的战略举措。
Fed Pract. 2020 Aug;37(Suppl 4):S76-S80. doi: 10.12788/fp.0019.
4
Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.局部立体定向消融增敏放疗用于治疗体积较大的非小细胞肺癌：一项回顾性研究。
Onco Targets Ther. 2018 May 8;11:2571-2579. doi: 10.2147/OTT.S159538. eCollection 2018.
5
Lobectomy: no port at all?肺叶切除术：完全不做端口（操作）？
Ann Transl Med. 2017 May;5(Suppl 1):S9. doi: 10.21037/atm.2017.03.22.
6
Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.非小细胞肺癌放射治疗技术与实施的进展：调强放射治疗、质子治疗和立体定向体部放射治疗的优势
Transl Lung Cancer Res. 2017 Apr;6(2):131-147. doi: 10.21037/tlcr.2017.04.04.
7
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.I期非小细胞肺癌患者立体定向消融放疗后的7年随访：一项2期临床试验的结果
Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.
8
Stage I lung cancer-to operate or to radiate? that is the question.I期肺癌——选择手术还是放疗？这是个问题。
J Thorac Dis. 2016 Sep;8(9):2324-2327. doi: 10.21037/jtd.2016.08.36.
本文引用的文献
1
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?免疫疗法与立体定向消融放疗（ISABR）：一种治愈性方法？
Nat Rev Clin Oncol. 2016 Aug;13(8):516-24. doi: 10.1038/nrclinonc.2016.30. Epub 2016 Mar 8.
2
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.立体定向体部放疗治疗可手术和不可手术 T1N0M0 期非小细胞肺癌的前瞻性研究：日本临床肿瘤学组研究 JCOG0403。
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96. doi: 10.1016/j.ijrobp.2015.07.2278. Epub 2015 Nov 11.
3
SABR vs surgery for NSCLC in the media.媒体报道中关于非小细胞肺癌的立体定向体部放疗与手术治疗对比
Lancet Oncol. 2015 Sep;16(9):e422. doi: 10.1016/S1470-2045(15)00230-2.
4
Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?肺叶切除术与立体定向体部放疗治疗Ⅰ期非小细胞肺癌：事后分析能伪装成一级证据吗？
J Thorac Cardiovasc Surg. 2015 Sep;150(3):468-71. doi: 10.1016/j.jtcvs.2015.06.086. Epub 2015 Jul 14.
5
Do we know bad science when we see it?当我们看到糟糕的科学时，我们能识别出来吗？
J Thorac Cardiovasc Surg. 2015 Sep;150(3):472-3. doi: 10.1016/j.jtcvs.2015.07.032. Epub 2015 Jul 17.
6
Surgery versus SABR for resectable non-small-cell lung cancer.手术与立体定向消融放疗治疗可切除非小细胞肺癌的比较
Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1.
7
Surgery versus SABR for resectable non-small-cell lung cancer.手术与立体定向消融放疗治疗可切除非小细胞肺癌的对比
Lancet Oncol. 2015 Aug;16(8):e370-1. doi: 10.1016/S1470-2045(15)00036-4.
8
SABR in early operable lung cancer: time for evidence.早期可手术肺癌的立体定向消融放疗：是时候拿出证据了。
Lancet Oncol. 2015 Jun;16(6):597-8. doi: 10.1016/S1470-2045(15)70225-1. Epub 2015 May 13.
9
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.立体定向消融放疗与肺叶切除术治疗可手术的Ⅰ期非小细胞肺癌：两项随机试验的汇总分析
Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13.
10
Non-small cell lung cancer, version 1.2015.非小细胞肺癌临床实践指南（2015 年版）
J Natl Compr Canc Netw. 2014 Dec;12(12):1738-61. doi: 10.6004/jnccn.2014.0176.
Zotero 插件